Document Detail


Type 1 diabetes and LADA--occurrence of HLA-DRB1 *03 and DRB1 *04 alleles in two age different groups of diabetics.
MedLine Citation:
PMID:  21033293     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Type 1 Diabetes Mellitus (T1D) with an onset in adulthood and Late Autoimmune Diabetes of Adults (LADA) are connected with autoimmune insulitis (associated with islet cell autoantibodies) and the specific high-risk HLA class II genotype. The study was aimed at analyzing time and clinical characteristics of the diabetics with an onset of the disease after 35 y. (T1D and LADA). Main target of the study was to assess possible role of the old age onset and compare it with diabetics with the onset in the middle age (incl. analyzing HLA-DRB1 genotype). In the study, we included 103 diabetics with an onset of autoimmune diabetes at 35+ y. who were hospitalized and afterwards long-term observed in the diabetological outpatient department. 46 men and 57 women of the average age 65.7 +/- 13.8 y. (range 35-93 y.) were out of this number. 41 were assessed as the T1D patients and 61 as the LADA ones. As a control group we used 99 healthy individuals. Patients of the T1D subgroup developed diabetes in the age of 50.8 +/- 15.1 y. and of the LADA subgroup in the age of 52.6 +/- 12.8 y. Its duration in the time of this study was 10.7 +/- 11.6 y.; respectively 5.3 +/- 7.1 y. Fasting and postprandial C-peptide levels were statistically higher (p < 0.01) in the LADA subgroup vs. T1D. Obesity 1st and 2nd grade were present together only in 12.6%. BMI was not statistically significantly different between both groups. We found in our diabetic patients the predisposition alleles HLA-DRB1*03, HLA-DRB1*04 and particularly their combination. The occurrence of these HLA alleles is significantly higher in T1D patients in comparison to control groups (p = 0.01, OR = 4.0). In our study, the occurrence of the susceptible HLA-DRB1*03 and HLA-DRB1*04 alleles in T1D patients is higher than in LADA. The presence of these alleles identifies patients of high risk and requirement of insulin therapy. Since risk alleles are similarly present in middle and old age, environmental factors probably play similar role in these onsets of autoimmune diabetes.
Authors:
P Weber; H Meluzínová; H Kubesová; P Ambrosová; V Polcarová; P Cejkova; M Cerna
Related Documents :
6757023 - Empirical risk for insulin-dependent diabetes (idd) in sibs. further definition of gene...
10867713 - Proliferative responses to selected peptides of ia-2 in identical twins discordant for ...
16476123 - Trends in the use of oral antidiabetic drugs by outpatients in taiwan: 1997-2003.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Advances in gerontology = Uspekhi gerontologii / Rossiĭskai͡a akademii͡a nauk, Gerontologicheskoe obshchestvo     Volume:  23     ISSN:  1561-9125     ISO Abbreviation:  Adv Gerontol     Publication Date:  2010  
Date Detail:
Created Date:  2010-10-29     Completed Date:  2010-12-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100971443     Medline TA:  Adv Gerontol     Country:  Russia (Federation)    
Other Details:
Languages:  eng     Pagination:  243-8     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, Geriatrics and Practical Medicine, Faculty Hospital and Masaryk University, Brno, Czech Republic. p.weber@fnbrno.cz
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Age of Onset
Aged
Aged, 80 and over
Aging / genetics*
Alleles
C-Peptide / blood
Case-Control Studies
Diabetes Mellitus, Type 1 / diagnosis,  drug therapy,  epidemiology,  genetics*
Female
Gene Frequency
Genetic Predisposition to Disease*
Genotype
HLA-DR Antigens / genetics*
Hemoglobin A, Glycosylated / analysis
Humans
Hypoglycemic Agents / administration & dosage,  therapeutic use
Insulin / administration & dosage,  therapeutic use
Male
Middle Aged
Polymerase Chain Reaction
Predictive Value of Tests
Risk
Chemical
Reg. No./Substance:
0/C-Peptide; 0/HLA-DR Antigens; 0/Hemoglobin A, Glycosylated; 0/Hypoglycemic Agents; 0/hemoglobin A1c protein, human; 11061-68-0/Insulin; 128338-86-3/HLA-DRB1 antigen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Many EDs noncompliant with asthma guidelines.
Next Document:  Driving instructors.